IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
Hims stock surged above a profit-taking zone Friday after facing backlash over its provocative Super Bowl ad that criticized ...
IBD 50's Doximity Rockets 34%, Breaking Out, After Another 'Pristine' Quarter
Doximity, which ranks sixth on the IBD 50, broke out Friday and rocketed above a profit-taking zone after crushing ...
Investor's Business Daily on MSN3h
IBD Rating Upgrades: Fidelity Natl Info Svcs Flashes Improved Technical Strength
A Relative Strength Rating upgrade for Fidelity Natl Info Svcs shows improving technical performance. Will it continue?
infectiousdiseaseadvisor.com3h
Inflammatory Bowel Disease Tied to Higher Risk for Heart Disease
Men with inflammatory bowel disease face a higher risk for ischemic heart diseases, according to study findings.
Hosted on MSN4h
Cloudflare Earnings Top Estimates. Management Touts AI Opportunity.
Cloudflare stock rose on Q4 earnings and revenue that topped Wall Street targets while full-year 2025 revenue guidance met ...
Everyday Health6h
Ulcerative Colitis Diet: What to Eat and Avoid, 7-Day Meal Plan, More
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, while foods high in insoluble fiber, processed meat, spicy foods, dairy, and ...
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).